RCA
OGN icon

Runnymede Capital Advisors’s Organon & Co OGN Stock Holding History

Runnymede Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-545
Closed -$8.12K – 199
2025
Q1 		$8.12K Buy
+545
New +$8.38K 0.01% 213

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Runnymede Capital Advisors's OGN Position: Q2 2025 in Review

Runnymede Capital Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 545 shares — an estimated $8.12K sold.

Runnymede Capital Advisors first reported a position in OGN in Q1 2025 and held it in 1 quarter. The position peaked at $8.12K in Q1 2025. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Runnymede Capital Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Runnymede Capital Advisors sold 545 Organon & Co shares in Q2 2025, an estimated $8.12K.
  • Runnymede Capital Advisors first reported a position in Organon & Co in Q1 2025 and held it in 1 quarter.
  • Runnymede Capital Advisors's Organon & Co position peaked at $8.12K in Q1 2025.
  • 696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Runnymede Capital Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.